Botoxina.com

β0ToxinA Injectable - Type A

β0ToxinA Injectable - Type A

Our Botulinum Toxin Type A Product for Cosmetic Therapy

INTRODUCTION

After more than 10 years of continuing research targeted at monodose and multidose application of the type "A" molecule, we have developed 2 main types of injectable toxins:
The first in freeze-dried powder form.
The second, available in liquid form that does not require any dilution

β0ToxinA® Injectable

β0ToxinA® is perfectly compatible with all injectable C. botulinum toxins currently available. This allows physicians to use β0ToxinA® Topical Use Vial together with any such toxins, in slow and low responding subjects. 
The product is currently available only for distribution by Sealab Europe LLP authorized representatives.
Upon request, the set may be completed with β0ToxinA® oral Vitamin C.

How the Product is Made

β0ToxinA® Injectable (Botulinum Toxin Type A for therapy) is a sterile, lyophilized form of purified C. botulinum toxin type A, produced from the crude toxin of the culture of the Hall strain of Clostridium botulinum grown in a medium containing trypticase and yeast extract.
A series of purifying procedures are taken to form a crystalline complex consisting of the active high molecular weight toxin protein and an associated hemagglutinin. After re-dissolving and dialyzing the crystalline toxin, an accurate amount of the sterile filtered (0.2 microns) toxin is added to a solution containing gelatine-dextran-sucrose, then lyophilized.

Product Contents and Consistency

Each vial of β0ToxinA® contains 100 units (U) of C. botulinum toxin type A, 5mg of gelatine, 25mg of dextran and 25mg of sucrose. Dilute with sterile normal saline according to the different needs before using. The white loose production turns to be a colourless or yellowish transparent solution after the reconstitution. One unit (U) of β0ToxinA® corresponds to 1 LD50 of Botulinum Toxin Type A injected intraperitoneally into a laboratory mouse. β0ToxinA® could block neuromuscular conduction by inhibiting the release of acetylcholine and therefore cause local muscle flaccid paralysis.

Indications for Injectable Therapies

β0ToxinA® is indicated for the treatment of blepharospasm, hemifacial spasm in adults and some types of strabismus and strabismus which cannot be corrected through operation in patients 12 years of age and above.

Recommended Product Care

  • Dose: 100 U / vial
  • Shelf Life: 3 years from the date of freeze-drying
  • Storage: Store at temperature of -5 to -20°C. Maximum solution temperature 36°C.
  • Genuine Product: Please be sure to check the lot number of the product and the corresponding colour of the top*

*Please be aware that there are counterfeits on the market

Beware Counterfeit Products

It has been brought to our attention that there is a company counterfeiting our product and even putting it on the market with our brand name!
We would like to point out that each β0ToxinA® vial undergoes at least two quality control tests: for safety and sterility. Our product conforms to GMP standards.
We would like to remind you that, thanks to its formulation, β0ToxinA® is inimitable in not losing virtually any efficacy in case of temperature fluctuations.

Contact

SeaLab Europe LLP, Suite 36, 88-90 Hatton Garden, Holborn, EC1N 8PN, London (UK)

Telephone:+ 44 7077073252

Fax: +44 7077077653

Newsletter

To receive our newsletters please join our exclusive β0Toxina® Foundatium Members Club by completing the registration form:

sottomarino newsletter

Book a place on our tour of our mobile submarine research and production laboratory, when available.